首页> 外文期刊>Biotechnology Progress >Inhibition of endogenous miR-23a/miR-377 in CHO cells enhances difficult-to-express recombinant lysosomal sulfatase activity
【24h】

Inhibition of endogenous miR-23a/miR-377 in CHO cells enhances difficult-to-express recombinant lysosomal sulfatase activity

机译:CHO细胞中内源miR-23a / miR-377对内源miR-23a / miR-377的抑制增强了难以表达的重组溶酶体硫酸酶活性

获取原文
获取原文并翻译 | 示例
       

摘要

Difficult-to-express (DTE) recombinant proteins such as multi-specific proteins, DTE monoclonal antibodies, and lysosomal enzymes have seen difficulties in manufacturability using Chinese hamster ovary (CHO) cells or other mammalian cells as production platforms. CHO cells are preferably used for recombinant protein production for their ability to secrete human-like recombinant proteins with posttranslational modification, resistance to viral infection, and familiarity with drug regulators. However, despite huge progress made in engineering CHO cells for high volumetric productivity, DTE proteins like recombinant lysosomal sulfatase represent one of the poorly understood proteins. Furthermore, there is growing interest in the use of microRNA (miRNA) to engineer CHO cells expressing DTE proteins to improve cell performance of relevant bioprocess phenotypes. To our knowledge, no research has been done to improve CHO cell production of DTE recombinant lysosomal sulfatase using miRNA. We identified miR-23a and miR-377 as miRNAs predicted to target SUMF1, an activator of sulfatases, using in silico prediction tools. Transient inhibition of CHO endogenous miR-23a/miR-377 significantly enhanced recombinant sulfatase enzyme-specific activity by similar to 15-21% compared to scramble without affecting cell growth. Though inhibition of miR-23a/miR-377 had no significant effect on the mRNA and protein levels of SUMF1, overexpression of miR-23a/377 caused similar to 30% and similar to 27-29% significant reduction in endogenous SUMF1 protein and mRNA expression levels, respectively. In summary, our data demonstrate the importance of using miRNA to optimize the CHO cell line secreting DTE recombinant lysosomal sulfatase.
机译:难以表达(DTE)重组蛋白如多种特异性蛋白质,DTE单克隆抗体和溶酶体酶,使用中国仓鼠卵巢(CHO)细胞或其他哺乳动物作为生产平台,可制造难以生产性。 CHO细胞优选用于重组蛋白质产生,以便它们分泌与后期改性的人样重组蛋白质,抗病毒感染和熟悉药物调节剂的能力。然而,尽管在工程CHO细胞中进行了巨大的进展,用于高容量生产力,如重组溶酶体硫酸酶,如重组溶酶体硫酸酯酶代表了一个不良理解的蛋白质之一。此外,在使用MicroRNA(miRNA)对表达DTE蛋白的工程蛋白酶的工程蛋白酶,以提高相关生物过程表型的细胞性能,越来越感兴趣。据我们所知,没有进行研究以改善使用miRNA的CHO细胞生产DTE重组溶酶体硫酸酶。我们将MiR-23a和miR-377鉴定为MiRNA预测靶向SumF1,硫酸酶激活酶,在硅预测工具中使用。与扰扰相比,CHO内源性miR-23a / miR-377的暂态抑制显着增强了重组硫酸酶特异性活性,而不会影响细胞生长。虽然miR-23a / miR-377对mIR-23a / miR-377的抑制没有显着影响SUMF1的mRNA和蛋白质水平,但miR-23a / 377的过表达导致与30%相似,并且类似于内源SUMF1蛋白和mRNA的显着降低27-29%表达水平分别。总之,我们的数据证明了使用MiRNA优化CHO细胞分泌DTE重组溶酶体硫酸酶的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号